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ABSTRACT
The primary purpose of this research was to examine the effects of HRT in women with
acute estrogen deficiency from surgically induced menopause. The secondary purpose was to
evaluate how HRT improves symptoms of acute estrogen deficiency and quality of life (QOL) in
women using hormone supplementation. Peer reviewed articles published from 2000 to 2017
that were written in the English language with a focus on the use of HRT in women with acute
estrogen deficiency after surgical menopause were evaluated for relevance. Evidence suggests
the primary reason for decreased use of HRT is the associated risks outweighing the benefits;
however, this is not reflected in health care provider’s (HCP’s) clinical experience. HCP’s were
more likely to prescribe HRT for themselves or family members if they were experiencing the
negative side effects of estrogen deficiency due to surgical menopause, but not to women in their
care with similar clinical manifestations of menopause. Additionally, serious risks associated
with HRT for acute estrogen deficiency remain incongruent with HRT for women experiencing
natural menopause; although risk for breast cancer due to HRT was a universal concern. Risks of
HRT related to thromboembolism, stroke and heart disease, were discussed with comparison to
the undesirable clinical manifestations of menopause. Results indicate further education and
research is needed that explores the risks and benefits for HRT in women with sudden onset of
estrogen deficiency from surgical menopause.
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INTRODUCTION
In the United States (US), it is estimated that 1 in 9 women between 35-45 years of age
will undergo a hysterectomy, with another 40 percent also having a bilateral salpingooopherectomy (BSO) resulting in premature menopause (<40 years of age) or early menopause
(41-45 years of age) (Keshavarz, Hillis, Kieke, Marchbanks, 2002). Surgically induced
menopause results in the abrupt onset of menopause before the median age of natural
menopause. This results in estrogen deficiency that can lead to uncomfortable side effects within
a very brief period of time and with an unknown duration of effect. Hormone replacement
therapy (HRT), primarily used to treat acute estrogen deficiency, is the standard drug therapy to
alleviate the symptoms of surgically induced menopause. However, after questions arose
following the publication of results from the Women’s Health Initiative regarding negative longterm effects of HRT, research and development of HRT was drastically reduced in women with
surgically induced premature or early menopause (Shuster, Rhodes, Gostout, Grossardt, &
Rocca, 2010). Women that have undergone hysterectomy with BSO require estrogen
replacement in sufficient doses for a duration of time long enough to reduce the consequences of
negative physiologic and psychosocial effects caused by abrupt estrogen deficiency. However,
prescribing practices and drug therapy adherence for health-preserving estrogen replacement in
women with surgically induced menopause often differs between providers and varies amongst
use in women.
A disconnect exists between the need for HRT in women experiencing surgically induced
menopause and acute estrogen deficiency that is coupled with a lack of knowledge relating to
this type of drug therapy. The health risks and dangers associated with long term use of HRT
have negatively influenced estrogen replacement in women with induced, premature or early
1

menopause, potentially causing more long-term harm than good. Consequently, it can be
determined that more research is needed in the area of HRT and the ability of HRT to improve
quality of life (QOL) in women who suffer from surgically induced menopause symptoms.
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PROBLEM
After hysterectomy with BSO, many women suffer the symptoms of premature or early
menopause such as increased irritability, sexual dysfunction, and hot flashes. Oftentimes these
symptoms are severe and interfere with activities of daily living. HRT can relieve the symptoms
of menopause, however health risks associated with long term use of HRT after natural
menopause, such as significantly increased risk for breast cancer and cardiac disease, have
overshadowed HRT in cases of abrupt estrogen deficiency, where HRT has a physiologic and
psychologic benefit.
Understanding the risks and benefits related to HRT in a woman experiencing the clinical
manifestations of estrogen deficiency that is not due to natural causes is vital for health care
providers. Providing the best formulation and treatment plans for individually-tailored HRT
after surgically-induced menopause can be beneficial to health outcomes in both short term
treatment of symptoms and in long term overall health status.

3

PURPOSE
The purpose of this literature review was to examine HRT in women with acute estrogen
deficiency following surgically induced menopause. Sufficient evidence exists to suggest healthrelated benefits when HRT is initiated and encouraged in women after hysterectomy with BSO.
More support is needed to help determine the consistency of HRT replacement practices by
providers and reduction of menopause symptoms in women that use HRT following
hysterectomy with BSO.
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METHOD
An integrative review of the literature was performed that examined health care
provider’s use of HRT in women with estrogen deficiency after surgical menopause. Key terms
used alone and in combination for the literature search included: “hormone replacement
therapy*”, “surgical menopause*”, “TAH-BSO”, “health care provider*”, “risks”, and “estrogen
deficiency*”. Data bases for the search included: Cumulative Index to Nursing and Allied Health
Literature (CINAHL), Educational Resources Information Center (ERIC), Elton B. Stephens Co.
Host (Ebsco Host), Medical Literature On-line (Medline), and Psychological Information
Database (PsychINFO). Inclusion criteria consisted of peer-reviewed articles published from
2000 to 2017 that were written in the English language. Articles were also evaluated for
relevance to the topic, which included 1) estrogen deficiency following TAH-BSO and natural
menopause, 2) health care provider’s perceptions of HRT in surgical and natural menopause, and
3) risks versus benefits of HRT in women with sudden onset of estrogen deficiency. Sentinel
articles from earlier studies were analyzed for historical context to the topic. Excluded articles
focused on HRT used for conditions that did not involve surgical or natural menopause, health
care providers that only used homeopathic or bioequivalent hormone therapies for estrogen
replacement, and women using HRT that were still of child-bearing age.
Each article was evaluated and individually critiqued for relevance to the topic and
application to HRT in women with estrogen deficiency. Subsequently all the critiques were
synthesized by the researcher and key data was extracted. Consistent and inconsistent findings
were noted along with gaps in the literature. Recommendations for future research were
identified. Implications for nursing practice, policy and education were included along with
limitations of this review.
5

BACKGROUND
Natural vs. Surgical Menopause
In the early 1990’s, hormone replacement therapy (HRT) for women experiencing
hormone imbalance due to menopause first came into mainstream use as drug therapy to relieve
symptoms associated with estrogen loss. Since then, the benefits of HRT have been recognized
as an integral therapy in postmenopausal women to help offset the side effects of menopause.
The undesirable side effects associated with menopause often include increased irritability, night
sweats, fatigue, bone loss, hot flashes, reduced sex drive, and vaginal dryness. The side effects of
estrogen deficiency can greatly interfere in a woman’s perceived quality of life and can lead to
problems such as depression and overall dissatisfaction with quality of life. When a woman
reaches the onset of menopause, the unpleasant side effects begin slowly and gradually worsen
as hormone levels naturally decline. This process happens at a much slower pace than in women
that undergo surgical menopause during a procedure known as a total hysterectomy with a
bilateral salpingo-oophorectomy. A bilateral salpingo-oophorectomy with total hysterectomy
(TAH-BSO) is a surgical procedure that removes the uterus, ovaries, and Fallopian tubes of a
woman who has not gone through menopause.
A TAH-BSO is often performed to eliminate the unpleasant side effects of menstrual
disorders, to eliminate cancers from the body, or to reduce risk of developing reproductive tract
cancers in women with significant family history. This non-elective surgery is a very serious
decision that women of potentially reproductive age must make in order to preserve their own
health either in the present or the future. After the procedure, a sudden onset of symptoms similar
to natural menopause is often reported to be more intense and long-lasting than a typical
menopause trajectory. Women who undergo TAH- BSO experience menopausal symptoms more
6

rapidly and report greater dissatisfaction with life, and overall decreased quality of life compared
to women who go through menopause gradually. Abadi et al. (2018) write that among the 22
Iranian women sampled a “feeling of an invisible wall” was the main theme and the reflection of
women's experience of sexual/marital relationship after surgical menopause. The wall felt by
these women is an apt analogy to the feelings of sexual dissatisfaction and disfunction
experienced by many women who undergo surgical menopause. Further exploration of sexual
function and the effects of both surgical and natural menopause was done by Toptan and Yildiz
(2012) who determined a significant positive relationship between the intensity of the symptoms
experienced in menopause and the problems experienced in sexual functions, especially in
women who underwent surgical menopause. The positive relationship found between menopause
symptom levels and the levels of sexual function problems indicates the importance of managing
symptoms in menopausal women: as such, the better women are able to manage their
menopausal symptoms, the more sexual functions will be positively affected (Toptan and Yildiz,
2012). In addition to the psychological symptoms, increased risk of osteoporosis, heart disease,
and stroke, due to estrogen deficiency can affect physical well-being during the changes that
occur in menopause. The clinical manifestations of estrogen deficiency after TAH-BSO are
mostly preventable through the use of hormone replacement therapy.
Perception of Hormone Replacement Therapy
HRT in post-menopausal women has had a controversial past. The Women's Health
Institute released a paper advising against HRT in the early 2000s, and a moratorium was
effectively instituted against hormone replacement in post-menopausal women. The risks of
HRT also included women with acute estrogen deficiency due to surgical menopause. The risks
associated with HRT have been further researched in the last 10 years, resulting in significant
7

benefits in the advancement of treatment specific to women with a rapid onset of estrogen
deficiency caused by TAH-BSO. However, many health care providers remain reluctant to
prescribing HRT in women with estrogen deficiency after TAH-BSO.
One Latin American study shows that the average provider will only prescribe hormone
replacement therapy to 50% of their client population that has shown need (Danckers, et al.,
2016). Many providers continue to believe that hormone replacement therapy can cause more
harm than good. Numerous Studies have raised concerns regarding the risk-benefit ratio of
hormone replacement therapy. The most common perceived risks of HRT in post-menopausal
women are breast cancer and thromboembolism, as well as stroke and heart disease (Chubaty,
Shandro, Schuurmans, & Yuksel, 2011). Subsequent studies have shown that the risks associated
with HRT affect an average of 6 out of 1000 women that use hormone replacement therapy
(Beral, Banks, & Reeves, 2002). Due to the systemic effects of ovarian hormones, other areas of
the body must also be considered when looking at potential risk. Bone mineral density reduction
is also a concern following surgical and natural menopause. At this time, no evidence exists to
say that surgical menopause makes this condition worse over time (Fakkert et al., 2017).
Psychological concerns have also been noted in women, who often see an increase in, or
new onset of, anxiety attacks following surgical menopause due to the physiological loss of
estrogen. Anxiety attacks are often more prominent in women with no prior psychological
history of such attacks (Chung-Park, 2005). The most common complaint from women who
undergo this procedure is decreased vaginal lubrication. Decreased lubrication leads to sexual
dissatisfaction and a less-positive body image perception (Kokcu et al., 2015). Finally, it has also
been shown that hormone therapy does not prevent stroke occurrence but does have a small but
statistically significant increase in ischemic stroke risk with standard doses of estrogen as well as
8

with estrogen and progesterone combined (Lobo, 2007). All such risks have been evaluated and
have been shown to have a marginal effect on women.
Actual Use of HRT
Inconsistencies exist regarding prescription practices of health care providers offering
women HRT after TAH-BSO. Approximately 80% of providers in a Latin American study said
that they would prescribe hormone replacement therapy to themselves or a loved one who was
experiencing the symptoms of sudden onset menopause. The same practitioners also report a 30
to 50% prescription rate for women in their practice who exhibit the same signs and symptoms
they would treat themselves for (Danckers, et al., 2016). Similar studies offer no reason for a
lack of HRT prescription other than perceived risk. This inconsistency between ideology and
practice needs to be more thoroughly assessed. Gender concerning health care providers was of
significant value for inconsistencies related to HRT in surgical menopause. Male providers were
less likely to empathize with the signs and symptoms that are presented by women who undergo
surgical menopause procedures. However, empathy only increases slightly within female
practitioners (Danckers, et al., 2016).
Summary
Overall, further education and research is needed for healthcare providers and women,
regarding the need for HRT in women with acute estrogen deficiency from TAH-BSO. Use of
HRT in women with acute estrogen deficiency can help improve physiologic and psychosocial
well-being in women following TAH-BSO through relief of acute estrogen deficiency
symptoms, such as hot flashes, hair loss, and fatigue. The literature suggests that the long-term
benefits of HRT for surgically induced menopause outweigh the risks for harm. HRT can
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improve long term health status for disease prevention and slow the progression of chronic
disease processes.
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RESULTS
Natural and Surgical Menopause
Twenty-nine articles related to HRT use in surgically postmenopausal women were
included in this review of literature. Of these articles, the majority (14) where cross-sectional by
design, with other categories including meta-analysis, randomized controlled trials, longitudinal
studies, case reports, and descriptive research. The majority of the studies were published within
the last ten (10) years with several outliers included due to background information valuable to
the topic. Cross-sectional studies included primarily used validated surveys and questionnaires as
assessment tools. Meta-analysis included two or more related studies that had clinical impact on
the use of hormone replacement therapy. Randomized controlled trials we're mostly done in
animal populations to explore the effects of hormone replacement therapy. Case reports (2) were
also gathered to show the severity of menopausal symptoms associated with acute estrogen
deficiency initiated by surgical menopause. One position statement by The North American
Menopause Society was also included due to recent publication and relevance to the topic.
The majority of amassed research in this literature review states that hormone
replacement therapy has more benefits than risks. One of the main benefits reported from use of
HRT includes reduced or eliminated symptoms of menopause including hot flashes, mood
dysregulation, insomnia, and night sweats. Additional research indicates improvements in sexual
relations and satisfaction do to increase vaginal lubrication (Kocku et al., 2015). Kocku et al.
(2015) also determined that women who underwent surgical menopause experienced more
profound vaginal dryness then women who went through natural menopause. Hormone therapy
such as progestin creams were found to improve vaginal lubrication in this population. Use of
hormone replacement therapy in surgically postmenopausal women also led to a decreased
11

perception of severity of surgery, meaning that women prescribed HRT were less likely to
negatively perceive their surgery in terms of post-surgical menopausal symptoms severity
(Tucker et al., 2016).
Hormone replacement therapy has been shown to affect multiple body and organ systems
in the women who use it. One study indicated that pre-surgical diagnoses of anxiety and
depression were augmented by acute estrogen deficiency that resulted from surgical menopause
were both found to be reduced or relieved by hormone replacement therapy (Chung-Park, 2006).
Colorectal cancer and femoral neck fractures we're also found to be reduced after a five-year
period of use in 1.7 / 1,000 users aged 50 to 59 years and 5.5 in 1000 users ages 60 to 69 (Beral,
Banks, & Reeves, 2002). Fakkert et al. (2017) conducted a seventeen (17) study meta-analysis
that indicated bone mineral density after surgical menopause was significantly lower than in
premenopausal age matched women but not lower than in women with natural menopause.
However; HRT has been found two reduce the incidence of bone fractures due to decreased
mineral density in other trials (Buist et al., 2004). HRT has also been found to positively
influence a limited number of olfactory and cognitive measures during menopause. These
measures were specifically related to odor memory and discrimination which were both
positively influenced by HRT with some additional implications in reducing the incidence or
severity of Alzheimer's type dementia in postmenopausal women (Doty et al., 2015). Research
has also demonstrated that surgical menopause correlates with a faster decline in certain
cognitive domains, and early start of postmenopausal hormone therapy serves as a protective
factor for this decline (Pines, 2014).
Finally, limited research also existed to demonstrate that HRT reduces the incidence of
diabetes mellitus in postmenopausal women. A similar study also demonstrated that estrogen
12

therapy could improve glycemic control in postmenopausal patients with type 2 diabetes,
although disparate results have also been reported (Otsuki et al., 2007). Even positive
cardiovascular effects are reported with use of HRT, contrary to previous thought. Sanghvi et al.
(2018) report that HRT use was not associated with adverse, subclinical changes in cardiac
structure and function but was associated however; with, significantly smaller left ventricle and
left atrial chamber volumes, which are linked to favorable cardiovascular outcomes.
Provider Perceptions of Hormone Replacement Therapy
The literature review also revealed a discrepancy between provider attitudes toward HRT
and their rates of prescription. Two articles that discussed prescriber patterns showed that
prescribers were very willing to prescribe HRT to themselves or a family member experiencing
symptoms of surgical menopause but were not as willing to prescribe such treatment to their
clients. One study specifically found that though 85.4% of providers would use HRT for
themselves or a partner, only 48.9% of women who showed a need for this therapy were given a
prescription. This same study also revealed that approximately 40% of providers surveyed placed
a risk level severity of 5/10 on the use of HRT, citing that thromboembolism and breast cancer
development were the highest perceived risks (Danckers et al., 2016).
The second article that highlighted the discrepancy between provider practice and
personal beliefs sought to determine whether physician’s confidence in the use of HRT for
climacteric symptoms had been affected by the negative media interpretation of HRT that has
emerged from recent research. The article reveals that 78% of physicians interviewed felt that
recent negative portrayal of HRT by the media was unjustified, and that the majority of
Physicians surveyed (90%) believe that the benefits outweigh the risks of HRT in suitable cases.
Additionally, almost all physicians (97%) believe that the majority of women experienced
13

positive health benefits which HRT. Similar to the previously cited article almost all physicians
(96%) would treat themselves spouse or family member with hormone replacement therapy
(Birkhauser and Reinecke, 2008).
The third article that discussed provider practice in HRT usage revealed that of the 70
women sampled, only 40% were prescribed HRT after a surgical menopause procedure.
Approximately 10 months after the surgery, when the survey was administered, only 33% of the
women were still taking their prescribed regimen. When this rate was compared to similar
studies done in North America it was approximately 40% lower than previous rates of
prescription and adherence. This is likely due to the impact of the WHI report regarding HRT
use and risk (Chubaty, Tami, Shandro, Schuurmans, & Yuksel, 2011).
The overall attitude surrounding HRT in this literature review is skeptical regarding the
effects of long and short-term use of HRT. The majority of these concerns are founded in the
research from the WHI paper which stated that HRT use could be correlated to breast cancer
development, as well as thromboembolism, strike, and cardiac disease (Writing Group for the
Women's Health Initiative Investigators, 2002). What has been discovered since research has
been continued is that though these risks are present, they are in very small numbers. The
cumulative risk for these diseases and conditions is approximately 1 in 1000 cases (Beral, Banks,
& Reeves, 2002). Educating providers regarding the prevalence of these risks is necessary to
ensure that they are educated enough to prescribe and discuss this medication option with the
women who show a need for this therapy.
Prescription Adherence and Therapy Continuation
An unexpected finding across several research studies analyzed relates to prescription
adherence. It was noted that when groups of women were assigned HRT after their surgical
14

menopause procedure only a handful of them were still taking their prescribed regiment when the
studies were conducted, an average of six months to a year later (Chubaty, Tami, Shandro,
Schuurmans, & Yuksel, 2011). The reasons for therapy termination were not determined by the
studies but are worth studying in the future. Understanding the actual client-experienced side
effects and both long and short-term feelings towards hormone replacement therapy is integral to
understanding usage patterns of HRT over time. If the prescribed therapy does not work for a
woman, that woman is more likely to not adhere to the prescribed regimen and not receive the
benefits of the therapy. Understandably, each woman who is prescribed hormone replacement
therapy had different hormones from others before their procedure, and all will have varying
hormone levels post-surgically as well.
Due to standardized research and case study reports, it is understood that differences
exist between women who undergo surgical menopause and are prescribed hormone replacement
therapy. Tailoring HRT dosages to the individual who has undergone a TAH-BSO is vital to
ensuring that all women are given the opportunity to come back from recovery with balanced
hormones. Changing the focus from an estrogen-progestin base to a formulation that consists of
estrogen is shown to reduce the long-term risks associated with HRT and should be more
thoroughly researched (Jin, 2017). Additionally, conjugated equine estrogen (CEE) use among
postmenopausal women was not associated with risk of all-cause, cardiovascular, or cancer
mortality during a cumulative follow-up of 18 years after a usage period with a median of 7.2
years (Manson et al., 2017). Lack of adherence must also be studied in these populations so that
perceived and actual effectiveness of hormone replacement therapy can be compared and
contrasted side by side in a way that sheds light on potential future practice patterns.
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DISCUSSION
The studies reviewed in this work provide insight into the benefits and risks HRT as well
as prescription patterns and women's adherence to treatment. Research findings revealed the role
and potential use of HRT in managing the menopausal symptoms of acute estrogen deficiency
induced by surgical menopause. While the review of literature showed occasional mixed results,
the use of HRT exhibits several positive effects on client outcomes. The literature also suggested
that more research needs to be done into the long-term effects of HRT in order to help women
make educated choices regarding their care after surgical menopause.
Natural vs. Surgical Menopause
After conducting a multi-layer search of hormone replacement therapy for surgically
postmenopausal women it has been suggested that two types of hormone loss exist: acute and
chronic. Natural menopause results in a long-term or chronic deficiency in gonadal hormones
that cause the expected manifestations of menopause as they deplete. Natural menopause has the
benefit of occurring more slowly than surgical menopause, meaning that hormone levels drop
gradually over time instead of instantaneously. Surgical menopause results in an acute cessation
of hormone genesis by the removal of the glands and organs that create them. Such rapid of
hormone generation causes the same symptoms as natural menopause, but to a greater severity
that negatively impacts quality of life.
Differentiating between acute and chronic hormone loss shows the need for even
temporary hormone replacement therapy in surgically postmenopausal women to soften the blow
of acute hormone loss. By starting women on HRT regimens immediately after surgery and
weaning them off slowly, the more severe adverse effects of menopause become diminished and
16

approximately equal to the severity of side effects experienced in natural menopause. One study
indicated that the only statistical difference between the after effects of surgical and natural
menopause was lubrication. Vaginal lubrication was found to be more profoundly affected in
women who underwent surgical menopause, but this effect was reduced with the addition of
HRT to the post-surgical medical routine (Kocku et al., 2015).
While the initial impact of surgical menopause is intense, over time the hormone
deficiency is adjusted to, and symptoms become more typical of natural menopause.
Replacement therapy can be used to dull the effects of sudden onset menopause as has been
discussed. From this literature review it has been gathered that the use of hormone replacement
therapy for a short period of time does not cause the long-term negative side effects that where
indicated in previous research. In fact, it has been determined by one study that a five to sevenyear usage of hormone replacement therapy is not associated with risk of all-cause,
cardiovascular, or cancer mortality during a cumulative follow-up of 18 years (Manson et al.,
2017). Educating women regarding the differences between acute and chronic hormone loss is
important because the differences between the severities of both types of hormone withdrawal
are vast. Understanding the ways the body will react to hormone reduction is also important
when deciding between treatment options for replacement therapies.

Current Use of Hormone Replacement Therapy
Hormone replacement therapy has been evaluated time and time again to determine if
benefits outweigh risks associated with the therapy. Current literature suggests that overall,
providers and prescribers of hormone replacement therapy have a positive opinion of hormone
replacement therapy as it relates to reducing the climacteric effects of menopause. Multiple study
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suggested that providers would prescribe hormone replacement therapy for themselves or their
loved ones if they were experiencing the symptoms of surgical menopause (Danckers et al.,
2016; Birkhauser and Reinecke, 2008). As was stated before, the main determinant of hormone
replacement therapy use in a client population is the conflicting information given regarding the
risk to benefit ratio for Moen replacement therapy.
Even when hormone replacement therapy is prescribed a majority of women stop taking
the therapy within a year of prescription (Chubaty, Shandro, Schuurmans, & Yuksel, 2011).
more research needs to be done in two reasons why women are stopping HRT before the end of
their treatment plan. It can be assumed that women who stop therapy before the end of its course
are unhappy with the way the therapy interacts with their body systems. An emphasis has been
recently placed on individualized therapies regarding hormone replacement for women with
surgical menopause. Individualized therapy promotes patient adherence in that hormone needs
are being met to the degree that they are needed in the individual woman as opposed to being
made on a generalized scale. Moving forward, individualized hormone levels testing needs to be
implemented in women who are prescribed HRT so that their pre-surgical hormone levels are
more efficiently reestablished after surgical menopause.

Quality of Life on Hormone Replacement Therapy
The main indication of HRT in surgically postmenopausal women is the relief of
climacteric symptoms associated with acute estrogen deficiency. Micronized progesterone
administered to postmenopausal women leads to significant improvements in quality of life
measures based on specific menopausal symptomatology. Symptoms that are improved by HRT
use include sleep problems, anxiety, cognitive difficulties, feelings of attraction, sexual
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functioning, and vasomotor symptoms (Fitzpatrick, Pace, & Wiita, 2000). In this literature
review, the most frequently reported positive outcome of HRT use is actual or perceived increase
in sexual desirability and function. Most women reported that when these feelings of desirability
and attractiveness were increased, other vasomotor and psychomotor symptoms were also
reduced (Tucker et al., 2016). This finding lends credence to the idea that surgically induced
menopause is a procedure with just as many psychological consequences as well as physical.
Ensuring that providers are aware of the psychological effects of a TAH-BSO will promote not
only the use of HRT but other methods of menopausal symptom control. Increasing symptom
control in surgically postmenopausal women will lead to an increase in positive outcomes postsurgically.

Benefits of Hormone Replacement Therapy
As with any type of medical intervention, risks and benefits need to be evaluated
on both a population and individual basis. After the Women's Health Initiative released their
research in 2002 regarding high risks associated with HRT, prescription rates dropped by
approximately 60% (Hersh, Stefanick, & Stafford, 2004). Research involving HRT also dropped
off as it was deemed unsafe to continue research on human subjects. The cessation of research
that resulted from the release of the Women's Health Initiative paper posed a severe problem for
the development of hormone replacement therapy that is still being felt today. After the advent of
the WHI, many studies were conducted that more closely examined the benefits of hormone
replacement therapy as it affects multiple body and organ systems. The temporary cessation of
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hormone replacement therapy research ultimately served to create an exponential increase in
research pertaining to risks and benefits of hormone replacement therapy.

Barriers to Implementation
The main barrier to implementation of HRT is a perceived lack of knowledge regarding
the benefits and risks of the therapy. While a wide dearth of research exists regarding the
benefits and risks of HRT, prescribers still remain on the fence regarding the validity of these
results. Overall opinions of hormone replacement therapy are favorable with a majority of
physicians stating that they would prescribe the therapy to themselves or their loved ones if
experiencing the symptoms associated with acute estrogen deficiency (Danckers et al., 2016;
Birkhauser and Reinecke, 2008). The core factor in the lack of prescription of hormone
replacement therapy lies in a lack of longitudinal research that is able to significantly compare
benefit-to-risk ratios. As the time this therapy is commercially available increases, more
crystallized results regarding an actual benefit-to-risk ratio will be found. The fear of possible
negative client outcomes is a major preventive factor for the prescription of hormone
replacement therapy in the opinion of many prescribers. What should be more important than
prescriber preference is client preference. Women need to be educated regarding their post
surgical options in menopausal symptom management, including HRT and other nonpharmacological options. As time progresses, information will become more readily available
and more informed decisions will be able to be made by women who undergo surgical
menopause.

20

LIMITATIONS
Several limitations were noted in this review of the literature. Initial search results
revealed numerous findings on keywords hormone replacement therapy, surgical menopause,
and women; however, fewer original research articles were relevant to the purpose of this
investigation. Fewer than ten (10) initial results met inclusion criteria for this review of literature.
Search terms were expanded to include keywords including postmenopausal, sexual satisfaction,
and bioidentical in order to provide more search results. This limitation is an indication of the
Lack of research pertaining to women who have undergone surgical menopause and indicates a
need for more research pertaining to this population. Inclusion and exclusion criteria are
subjective in nature, and that's limit this review of literature.
Many of the studies were limited by small sample sizes and small durations. Only a few
studies were longitudinal and collected data for over a year. the majority of studies included
small but specific populations, which limits the generalizability of the findings. the largest
sample size was over 10,000 women in size, but only served to describe use of hormone
replacement therapy during a time when it was not widely prescribed (Beral, Banks, & Reeves,
2002)). Reasons for taking hormone replacement therapy we're not delineated in this study, and
therefore results cannot be ascribed to women who have undergone surgical menopause.
Retention of participants also posed a problem in evaluating the long-term effects of
hormone replacement therapy. Several studies noted that a high attrition rate existed within their
studies meaning that not all women who were prescribed hormone replacement therapy followed
through in the manner in which they were instructed. Having a limited number of longitudinal
studies further limits this literature review due to the lack of information regarding long term use
of hormone replacement therapy. It is important to note however; that it is not uncommon for
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research studies requiring regular medical intervention to have high rates of attrition has some
participants may not find the therapy beneficial, insurance is changed, or the participant moves
out of the demographic targeted by the study.
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RECOMMENDATIONS FOR HORMONE REPLACEMENT THERAPY
Implementation of Hormone Replacement Therapy
Hormone replacement therapy is a treatment option for the severe after-effects of surgical
menopause that can improve quality of life in women who participate in the therapeutic regimen
(Rodriguez and Shoupe, 2015). Health care providers play a significant role in the
implementation of hormone replacement therapy for surgically postmenopausal women.
Research overall has shown the benefits of hormone replacement therapy and surgically
postmenopausal women range from improvement in quality of life to improvement in function of
organ systems. The use of HRT to reduce the severity of menopausal symptoms following
surgical menopause is dependent on both the prescriber and the woman receiving the therapy. A
discrepancy has been shown between personal opinion and actual practice of providers regarding
hormone replacement therapy (Danckers et al., 2016). Understanding the risks and benefits of
HRT is a burden that should be equally shared between the prescriber and the recipient of the
therapy. Open communication between prescribers and HRT recipients promotes safe and
effective use of the therapy.
Education regarding hormone replacement therapy should be standard practice for
women who are preparing to undergo surgical menopause. By having an understanding of the
therapy, prescribers have the ability to help women make informed decisions regarding their
treatment plans after their surgery. Tasneem et al. (2017) found that in addition to education
among providers lacking in breadth and scope, no decision aid tool (DAT) exists to help women
make decisions regarding management of their menopausal symptoms. In fact, most DATs
focused on HRT as the only treatment option for menopausal symptoms which excludes many
other treatment options available to surgically postmenopausal women( Siyam, Sultani, Ross,
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Chatterley, & Yuksel, 2017). More research is also needed in this area in order to delineate the
risks and benefits of hormone replacement therapy in this population more firmly. Healthcare
providers can play an equal role in both client education and research development regarding
HRT.

Research
Further research is needed to help healthcare professionals weigh the risks and benefits of
hormone replacement therapy as they pertain to individual women. Generalizations about HRT
and its effect on the surgically post-menopausal woman are dangerous in that they do not
account for the baseline health differences between women in a similar population.
The majority of studies gathered in this literature review used relatively homogeneous
populations to study the risks and benefits of HRT. In order for search results to be more
generalizable to the overall population research studies need to pull from a heterogenous pool of
participants that vary in age and demographic information. Additionally, sample sizes need to be
increased in size as well as diversity. Several studies pulled had high rates of participation but
even these were subject to significant attrition rates over the time in which the study was
conducted. As HRT is continually used in practice for women who have undergone surgical
menopause it will become easier to create longitudinal studies that clearly demonstrate the longterm effects of hormone replacement therapy.
Further research is also needed to determine if non-prescription from prescribers is the
main reason that women are not taking hormone replacement therapy after surgically induced
menopause, or if the reason is multifactorial. One study indicated that of women taking hormone
replacement therapy immediately after surgical menopause, only 33% percent were still taking
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therapy after 10 months (Chubaty, Shandro, Schuurmans, & Yuksel, 2011). The reasons behind
this elevated level of non-compliance with HRT post surgically needs to be examine in a
homogeneous and large population in order to determine perceived effectiveness of hormone
replacement therapy in this population.

Education
Education of healthcare providers is essential to successfully implement hormone
replacement therapy used in surgically postmenopausal women. Literature findings suggest that
women are interested in using medical intervention in order to reduce the severity of menopausal
symptoms associated with surgical menopause, but that public opinion and discourse do not
allow for information regarding safe practices to be widely disseminated (Burrell, Valledor,
Crowe, & Whitehead, 2010). A foundation of knowledge is needed to understand the overall
long and short-term effects of HRT. Any member of the healthcare team who will be interacting
with a woman using HRT needs a fundamental knowledge regarding the therapy and its
implementation.
In addition to having an internal wealth of knowledge, healthcare providers need to have
resources available to show women who have undergone surgical menopause. The information
disseminated by these resources should be factual, current, and simply stated in order to achieve
maximum benefit. This information should also be available regarding different formulations of
hormone replacement therapy including the estrogen-only modality that is gaining interest in
recent years (Jin, 2017). Bioidentical hormones should also be considered as they are also in a
developing field (Manson et al., 2017). What remains after all this information is gathered and
distributed to women is making sure that the physician or prescriber of HRT as well as the entire
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healthcare team, is able to follow up with the woman on this therapy in order to ensure that best
practice is being used. Women who are followed closely throughout their therapy feel that they
are able to freely discuss their treatment and manage it with the healthcare team which leads to
better adherence and satisfaction in the long run (Pezaro et al., 2012).

Medical Practice
Implication of hormone replacement therapy has many implications for all members of
the healthcare team. Prescribers, including doctors and nurse practitioners, need to have a firm
understanding of their clients Baseline health and needs before prescribing or using any form of
hormone replacement therapy. Individually tailoring therapy to women who have undergone
surgical menopause is important so that she receives the maximum benefit from her prescribed
therapy. Regular follow-up and evaluation of lab values needs to be implemented as a protocol to
ensure continued benefit over the course of the therapy. Phlebotomists and lab technicians need
to ensure that the woman receiving HRT is regularly being brought in for blood draws and lab
evaluations in order to keep hormones within a prescribed therapeutic range. Nurses also play an
important role in the delivery of HRT due to having a high level of direct patient contact. The
nurse is especially responsible for having factual information regarding HRT as they are often
the first person a woman sees when coming to a medical facility. Nurses need to have a wealth of
knowledge regarding HRT as they are often the sounding board for questions and concerns
regarding all types of medical intervention.

Conclusion
Hormone replacement therapy has the potential to change the way women recover from
surgical menopause. Prescribers need to understand the risks and benefits of HRT in order to
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help women create a treatment plan that helps them manage the negative side effects of surgical
menopause. This literature review suggests that HRT overall benefits women who have
undergone surgical menopause by reducing the severity of the menopausal symptoms felt after a
TAH-BSO (Kaur, Malla, & Gupta, 2017). However, some professionals are still unsure if the
benefits actually do outweigh the risks when prescribing hormone replacement therapy and
believe that hormone replacement therapy needs to be more thoroughly examined for adverse
long-term effects when used in this population (Crauciuc et al., 2013). The North American
Menopause Society has recently released a statement that is supported by over twenty
international agencies considered to be experts in menopause and women’s health. This
statement declares that: “Hormone therapy (HT) remains the most effective treatment for
vasomotor symptoms (VMS) and the genitourinary syndrome of menopause (GSM) and has been
shown to prevent bone loss and fracture. The risks of HT differ depending on type, dose,
duration of use, route of administration, timing of initiation, and whether a progestogen is used.
Treatment should be individualized to identify the most appropriate HT type, dose, formulation,
route of administration, and duration of use, using the best available evidence to maximize
benefits and minimize risks, with periodic reevaluation of the benefits and risks of continuing or
discontinuing HT” (The North American Menopause Society, 2017). Additional research needs
to be done into the new formulations for HRT for equal or better effectiveness with the potential
of fewer adverse health outcomes.
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APPENDIX A: FIGURE
Potentially relevant citations identified after a
screening of the databases (CIANHL,
MEDLINE, PubMed, PsychINFO)
Citations excluded due to not

(n=38,313)

meeting the search criteria
(n=28,526)

Studies retrieved for more
detailed review
(n=200)

Studies removed after a more
detailed review due to not
completely meeting inclusion
criteria
(n=150)
Relevant studies included that
met all inclusion criteria
(n=35)
Key Search Terms = surgical menopause AND hormone replacement therapy AND menopause AND risks AND
uses
Limiters = English language, peer-reviewed, full text online, publication date from 2000 to present

Figure 1: Consort Diagram of Thesis Methodology
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APPENDIX B: TABLE
Table 2: Table of Evidence of Reviewed Literature

Author(s), Year,
Location
Beral, V., Banks,
E., & Reeves, G.
(2002). Evidence
from randomised
trials on the longterm effects of
hormone
replacement
therapy. Lancet,
360(9337), 942.

Study
Design
Systematic
review

Four trials
analyzed

Sample
Size and
Population
N = 20,000
over four
studies

Significant
Risk Factors

Purpose
To determine the
effects of hormone
replacement therapy
over long-term in
regard to cancer of the
breast, endometrium,
and colorectum;
coronary heart disease;
stroke; pulmonary
embolism; and
fractured femur neck

Increased risk
of disease as a
result of using
HRT for over 5
years.

These disease
risk odds
increase with
increased age,
and are
anywhere
between 1.7 12 cases per
1000

Key Findings
Use of HRT over a five-year
period by healthy
postmenopausal women is
estimated to cause extra
breast cancer, stroke, or
pulmonary embolus in about
6 per 1000 users. however,
incidences of colorectal
cancer or fractured neck of
femur is reduced to 1.7 per
1000 users

Implications for
Practice
More research
needs to be done
to determine if
rare conditions are
affected by HRT.

Increase disease
risk must also be
determined when
utilizing other
formulations of
hormones such as
oestrogen or
progestin.

Actual percentage
of acquiring
disease must be
discussed while
determining HRT
formulations.
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Author(s), Year, Location
Birkhäuser, M. H., & Reinecke, I.
(2008). Current trends in hormone
replacement therapy: perceptions
and usage. Climacteric, 11(3), 192200.
doi:10.1080/13697130802060455

Study Design

Sample Size and
Population

Structured
N= 600
questionnaire physicians
completed via
internet
Physicians who
specialize in
Crosstreating
sectional
menopausal
survey
women

Physicians were
recruited from
the United States,
France,
Germany, the
United Kingdom,
Sweden, and
Poland

Purpose

Significant
Risk Factors

Key
Findings

Implications
for Practice

To determine
whether
positions
confidence in the
use of HRT has
been affected by
negative media
interpretation of
data from studies
investigating
HRT such as the
Women's Health
Initiative study

A profession
wide knee-jerk
reaction
occurred when
the WHI
released
evidence that
hormone
replacement
therapy was
more
detrimental
than beneficial

Almost all
Physicians
would treat
themselves
with HRT if
they were
having the
same
symptoms

Doing a critical
evaluation of
evidence before
all turn
treatment plans
is necessary in
order to
promote the
highest quality
of patient care.

5 years after
that study was
released, the
evidence was
reevaluated
and found not
as jarring

78% of
Physicians
felt that the
recent
negative
portrayal of
HRT by the
media was
unjustified

90% of
Physicians
believe that
the benefits
outweigh the
risks of
HRT in
suitable
patients
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It is important
to never
abandon the old
or adopt the
new too quickly

Author(s), Year, Location

Study Design

Buist, D. S., Newton, K. M., Miglioretti, D.
L., Beverly, K., Connelly, M. T., Andrade,
S., . . . Kessler, L. (2004). Hormone
Therapy Prescribing Patterns in the United
States. Obstetrics & Gynecology, 104(5),
part 1, 1042-1050.
doi:10.1097/01.aog.0000143826.38439.af

Observational
cohort study

Used
automated
Pharmacy data
to identify all
oral and
transdermal
estrogen and
progestin
dispensed
during the
study.

Sample Size
and
Population
N= 169586

Women aged
40 - 80 years
old who were
enrolled in
five Health
maintenance
organizations
in the United
States
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Purpose
Examine
prescribing
patterns for
estrogen plus
progestin and
estrogen
alone in the
United States
in the 2 years
before the
published
results of
women's
health
initiatives
(WHI)
hormone
therapy trials
early
termination
and for 5
months after
they release

Significant
Risk
Factors

Key Findings

WHI
hormone
therapy trial
indicated
that the risks
of using
hormone
therapy
outweigh the
benefits for
women
without
menopausal
symptoms

The diffusion of
the WHI
hormone therapy
trial results had it
in media impact
on the
discontinuation
of hormone and
estrogen therapy
and is likely
responsible for
the decline in the
initiation of the
Therapies

many
women were
not aware of
the results of
the WHI trial

Implications
for Practice
Informing
women
regarding the
risks and
benefits of
HRT helps
them to make
an educated
decision
regarding
their
treatment.

Further
exploration of
why women
continue to
use hormone
replacement
therapy are
indicated

Author(s), Year, Location
Chubaty, A., Shandro, M. L.,
Schuurmans, N., & Yuksel, N. (2011).
Practice patterns with hormone
therapy after surgical menopause.
Maturitas, 6969-73.
doi:10.1016/j.maturitas.2011.02.004

Study
Design
Crosssectional
chart
review
with
telephone
follow-up

Sample Size
and
Population

Purpose

N = 70

Charts selected
using ICD 10
codes for
hysterectomy
and BSO

Participants
were women
between the
ages of 20 and
50 who had
hysterectomy
or BSO
between
December 1st
2006 and
November 30th
2007
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To describe
practice
patterns with
HRT in
women after
surgical
menopause
and to
describe their
experience of
hot flashes
and other
menopausal
symptoms

Significant
Risk Factors
Many women
are not being
prescribed
hormone
replacement
therapy after
hysterectomy
and BSO
procedures

Key Findings
HRT can be
beneficial in
preventing
cardiovascular
disease and
osteoporosis in
women who
undergo surgical
menopause.
However, over
two-thirds of
women were not
on HRT after
surgical
menopause and as
a result were
having daily hot
flashes

Implications for
Practice
More education
prior to surgery
or a discharge
may increase
HRT prescription
rates.

Increase in
prescription rates
will reduce the
incidence of
menopausal
symptoms in
surgically
postmenopausal
woman

Author(s), Year,
Location
Chung-Park, M.
(2005). Anxiety
attacks following
surgical
menopause: a case
report. Holistic
Nursing Practice,
19(5), 236-240.

Study Design
Clinical case
report/ research
synthesis

Sample Size
and
Population

Purpose

Clinical case
was female 45
years old,
gravida 3, para
2 who
underwent total
abdominal
hysterectomy
with bilateral
salpingooophorectomy

To
determine a
causal
relationship
between
surgical
menopause
and
increased
anxiety
attacks
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Significant Risk Factors

Key Findings

Women experience mood
disorders more often than men

Psychological
disorders can
be a result of
menopause.

Implications
for Practice
Gathering a
psychiatric
history for
patients
undergoing
surgical
menopause is
important.

Symptom severity varies between
women. The severity is increased
in women with pre-existing mental These findings
health conditions
are more
severe in cases
of surgical
menopause.
Hormone
replacement
therapy should
To help reduce be considered
these
in women with
symptoms, an a history of
HRT regimen psychiatric
should be
disorders, or
considered
who are at risk
for developing
such a
disorder

Study Design

Sample
Size and
Population

Purpose

Significant Risk
Factors

Key Findings

Implications
for Practice

Author(s), Year, Location
Danckers, L., Blümel, J. E., Witis, S.,
Vallejo, M. S., Tserotas, K., Sánchez,
H., & ... Chedraui, P. (2016). Personal
and professional use of menopausal
hormone therapy among gynecologists:
A multinational study (REDLINC
VII). Maturitas, 8767-71.
doi:10.1016/j.maturitas.2016.02.015

Cross-sectional

N=1837

A selfadministered
and anonymous
questionnaire
was delivered
to certified
gynecologists
in 11 Latin
American
countries

Mean age
was 48.1,
55.5% were
male

To determine
the use of
HRT and
perceived
related risks
among
gynecologist

Percentage of
women using HRT
is very low,
possibly related to
lack of
prescription

Gynecologists
surveyed were
mostly supportive
of HRT use if
menopausal
symptoms were
present

Gynecologists are
still concerned
about the risk of
breast cancer and
thromboembolism

\
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The main
reason for the
low rate of
hormone
replacement
therapy use is
lack of
prescription

Latin
American
gynecologists
are mostly
supporters of
HRT use for
themselves or
their partners

This belief
does not
translate into
clinical
practice with
clients

Education of
women
regarding
HRT is
important

Education can
guide women
to ask the right
questions
regarding
HRT

Author(s), Year, Location
Doty, et.al (2015). Influences of hormone replacement
therapy on olfactory and cognitive function in
postmenopausal women. Neurobiology of Aging, 36(6),
2053-2059,
https://doi.org/10.1016/j.neurobiolaging.2015.02.028.

Study
Design
Crosssectional

a series of
olfactory
and
cognitive
tests were
given
during a 5
hour
session

Sample Size
and Population
N = 432

healthy
postmenopausal
women with
varying histories
of HRT
treatment

Peripheral
venous
blood was
then
collected
for
hormone
assays

Purpose
To evaluate the
influences of
HRT on tests of
odor
identification,
detection,
memory
discrimination,
and cognition

Significant
Risk Factors
Gonadal
hormone
deficiency
can lead to
cognitive
decline

Decreased
olfaction can
be an early
sign of
Alzheimer's
dementia

Beginning
hormone
replacement
therapy soon
after
menopause
produces the
greatest
benefit

Study was
single
blinded
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Key Findings
After
controlling for
age and IQ
odor memory
and
discrimination
is positively
influenced by
HRT

HRT was
found to have a
positive effect
on results from
the National
Adult Reading
Test (NARTIQ)

Implications for
Practice
Understanding
the role of
gonadal
hormones in
memory and
cognition can
help the
healthcare team
direct women
with risk of
memory
impairment
toward the use of
hormone
replacement
therapy soon after
menopause

Author(s), Year, Location
Fakkert, I., Teixeira, N.,
Abma, E., Slart, R., Mourits,
M., Bock, G., & ... de Bock, G.
H. (2017). Bone mineral
density and fractures after
surgical menopause:
systematic review and metaanalysis. BJOG: An
International Journal of
Obstetrics & Gynaecology,
124(10), 1525-1535.
doi:10.1111/1471-0528.14703

Study
Design
Systematic
review and
metaanalysis
conducted by
a literature
search

Sample Size
and
Population
17 studies
were included
comprising
43386 women
with surgical
menopause

Purpose
To investigate
bone mineral
density and
Fracture
prevalence
after surgical
menopause

10 studies
provided
sufficient data
for metaanalysis

Significant
Risk Factors
Sudden drop in
hormones
caused by
surgical
menopause can
possibly
increase the
risk of bone
fracture

Gradual
tapering of
hormones in
natural
menopause
possibly leads
to a less severe
increase in
bone fractures
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Key Findings
Lumbar spine and
femoral neck
fractures are more
common in women
with surgical
menopause than in
premenopausal agematched women

No consistent
differences were
observed for bone
mineral density or
fracture rate
between surgical or
natural menopause

Implications for
Practice
Ensuring that
women of
menopausal age or
women about to
undergo surgical
menopause have an
adequate amount of
calcium can reduce
reduction in mineral
density and fracture
incidence

Education regarding
bone density after
menopause of either
type can elevate
compliance in a
calcium regimen

Author(s), Year, Location
Fitzpatrick, L. A., Pace, C., &
Wiita, B. (2000). Comparison of
Regimens Containing Oral
Micronized Progesterone or
Medroxyprogesterone Acetate on
Quality of Life in Postmenopausal
Women: A Cross-Sectional
Survey. Journal of Womens Health
& Gender-Based Medicine, 9(4),
381-387.
doi:10.1089/1524609005002069

Study Design
Crosssectional
survey

QOL was
assessed via
telephone
interview
using the
Greene
Climacteric
Scale and the
Women's
Health
Questionnaire

Sample Size
and
Population

Purpose

N= 176

Women who
were
currently
using HRT
containing
micronized
progesterone
for 1 - 6
months and
had
previously
received HRT
containing
MPA
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to examine quality of
life related to
physiological, somatic,
and vasomotor effects
of changing
progestogen treatment
from
medroxyprogesterone
acetate (MPA) to
micronized
progesterone in
postmenopausal
women

Significant
Risk
Factors
Estrogens
produce
vaginal
bleeding in
about three
fourths of
women and
increase the
risk of
endometrial
cancer

Key Findings
Approximately
80% of women
who used
micronized
progesterone
HRT had
significant
improvement in
all around
symptoms and
reported an
increased
quality of life

Implications
for Practice
Understanding
that different
treatment
regimens work
differently for
everyone is
important to
providing the
highest quality
of care.

Trends in
prescription
patterns should
also be noted to
help make the
best fit more
quickly

Author(s), Year, Location
Hersh, A., Stefanick, M. &
Stafford, R. (2004). National
Use of Hormone Replacement
Therapy: Annual trends and
Response to Recent Evidence.
JAMA(291), 47-53.
doi:10.1001/jama.291.1.47

Study Design
The National
Prescription adult
database
provided data on
the number of
hormone therapy
prescriptions
filled by retail
pharmacies

Sample Size
and Population
Population data
was
extrapolated
using the
National
Prescription
Audit database
and the National
Disease and
Therapeutic
Index database

the national
disease and
therapeutic index
database
provided data on
patient visits to
office-based
Physicians during
which hormone
therapy was
prescribed

Purpose
To
describe
patterns of
hormone
therapy
used from
1995 until
July 2003

Significant Risk
Factors
Hormone
replacement
therapy
prescriptions
increase from 58
million in 1995
to 90 million in
1999, and then
remain stable
through June
2002

After the release
of the women's
Health Institute
report on the
risks associated
with hormone
replacement
therapy
prescription rates
rapidly declined
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Key Findings
Clinical
practice may
have responded
to rapidly to
recent evidence
of harms
associated with
hormone
therapy

Since July 2002
many patients
have
discontinued
HRT or are
tapering to
lower doses

Implications for
Practice
Actions from the
medical
community
directly affect
many aspects of
patient care
including
prescription rate,
quality of care,
and treatment
outcomes.

Fully
understanding the
important of
decision-making
in the profession
holds the
healthcare team
more responsible
for their actions

Author(s), Year, Location

Study Design

Jin, J. (2017). Hormone
Therapy for Primary Prevention
of Chronic Conditions in
Postmenopausal Women. Jama,
318(22), 2265.
doi:10.1001/jama.2017.18440

Evidence review
of the benefits
and harms of
systemic (ie, oral
or transdermal)
hormone therapy
for the prevention
of chronic
conditions in
postmenopausal
women

Sample Size and
Population
This
recommendation
statement applies
to asymptomatic,
postmenopausal
women who are
considering
hormone therapy
for the primary
prevention of
chronic medical
conditions
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Purpose
To update the 2012
US Preventive
Services Task
Force (USPSTF)
recommendation
on the use of
menopausal
hormone therapy
for the primary
prevention of
chronic conditions.

Significant
Risk Factors
The review did
not address
hormone
therapy for
preventing or
treating
menopausal
symptoms.

This statement
does not apply
to women who
are considering
hormone
therapy for the
management of
menopausal
symptoms, or
women who
have had
premature
menopause or
surgical
menopause.

Key Findings
The USPSTF
recommends
against the use of
combined
estrogen and
progestin and
estrogen alone for
the primary
prevention of
chronic conditions
in postmenopausal
women

Implications for
Practice
Understanding
medication
formulation
recommendations
can help provide a
higher quality of
client care

Author(s), Year,
Location
Keshavarz, H.,
Hillis, S.D., Kieke,
B.A., Marchbanks,
P.A. (2002).
Surveillance
Summaries.
MMWR.
Hysterectomy
Surveillance,
United States,
1994–1999; pp. 1–
8.

Study Design
Meta-analysis
and systematic
review of all
chart data for
women within
the appropriate
age and time
demographic.
The National
Hospital
Discharge Survey
was used to
gather the data

Sample Size
and
Population
women aged
>15 years who
had a
hysterectomy
during 1994-1999

Purpose
To gather data
on women who
have undergone
surgical
menopause and
to analyze
National Data
regarding pelvic
surgery in the
United States
population

Significant Risk
Factors
Uterine
leiomyoma,
endometriosis, and
uterine prolapse
were the most
common
indications for
hysterectomy

Women aged 4044 years old were
the most common
recipients of
hysterectomies

Key Findings
The total number
of hysterectomies
performed in the
United States
increased during
the time frame of
the study

55% of women
who had a
hysterectomy
during this time
also had a bilateral
oophorectomy, also
known as Surgical
menopause

The increase in the
number of
hysterectomies
performed
correlates with the
increase of use of
HRT
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Implications for
Practice
Understanding
menopausal causes
such as surgery and
properly identifying
early onset
menopause can help
women attain access
to HRT to increase
quality of life

Author(s), Year, Location
Kokcu, A., Kurtoglu, E.,
Bildircin, D., Celik, H., Kaya,
A., & Alper, T. (2015).
ORIGINAL RESEARCH:
Does Surgical Menopause
Affect Sexual Performance
Differently from Natural
Menopause?. The Journal of
Sexual Medicine, 1214071414. doi:10.1111/jsm.12891

Study
Design

Sample Size and
Population

Cross
sectional
survey

N = 243, 121 women
who underwent
surgical menopause
and 122 women who
underwent natural
menopause, who
were between the
ages of 45 and 65

Purpose
To investigate
whether
surgical
menopause
affect sexual
performance
differently than
natural
menopause

Significant
Risk Factors
The sudden
drop in
hormones
associated with
surgical
menopause
could cause
exacerbated
menopause
symptoms that
would reduce
quality of life

Key Findings
With the
exception of
lubrication
there were no
statistically
significant
differences
between
surgical and
natural
menopause

Implications for
Practice
Understanding the
lubrication needs of
sexually active
women after surgical
menopause can help
the healthcare team
guide women
proactively toward
lubrication solutions
to increase sexual
satisfaction

Understanding the
lubrication means of
non-sexually active
women is also
important to ensure
daily comfort quality
of life
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Author(s), Year, Location

Study
Design

Sample Size and
Population

Purpose

42

Significant
Risk Factors

Key Findings

Implications for
Practice

Lobo, R. A. (2007). Menopause and
stroke and the effects of hormonal
therapy. Climacteric, 10(Sup2), 2731.
doi:10.1080/13697130701550903

MetaPopulation for
analysis the study was the
population from
the Articles
included in the
meta-analysis

Menopausal and
postmenopausal
women between
the ages of 50 to
84

To determine the
relationship
between hormone
replacement
therapy and the
incidence of
stroke in
postmenopausal
women

Stroke is the
3rd leading
cause of
death in
women in the
U.S.

Stroke risk
increases
dramatically
after
menopause

Hormone
therapy does
not prevent
stroke
occurrence

A statistically
significant
increase in
ischemic stroke
risk with
standard doses
of estrogen as
well as with
estrogen/
progestogen

Data are
inconsistent
regarding
relationship
between HRT This risk is
and stroke
lowered with
earlier starts of
therapy, the use
of a lower
estrogen dose,
and the use of
unopposed
estrogen and
nonhypertensive
women
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Assessing the
cardiovascular
status of women
who will be using
hormone
replacement
therapy is
imperative to
adjust dosage
properly to
mitigate possible
increase in stroke
risk

Author(s), Year, Location
Manson JE, Aragaki AK,
Rossouw JE, Anderson GL,
Prentice RL, LaCroix AZ, …
Wactawski-Wende J. (2017)
Menopausal Hormone Therapy
and Long-term All-Cause and
Cause-Specific Mortality, The
Women’s Health Initiative
Randomized Trials. JAMA,
318(10):927–938.
doi:10.1001/jama.2017.11217

Study Design
observational
follow up of US.
multi-ethnic
postmenopausal
women aged 50 79 years enrolled
into randomized
clinical trials
between 1993
and 1998 and
followed up
through
December 31st
2014

Sample Size
and Population
N = 27347

Postmenopausal
women age 50 75 years who
were previously
enrolled in
hormone
replacement
therapy trials

Purpose
To examine
total and
cause specific
cumulative
mortality,
including
during the
intervention
and extended
post
intervention
follow-up, of
the two
Women's
Health
Initiative
hormone
therapy trials

Significant Risk
Factors
Conjugated equine
estrogens (CEE) plus
medroxyprogesterone
acetate (MPA) trial was
stopped early (after 5.6
years) due to an
increased risk of breast
cancer and overall risks
exceeding benefits; the
CEE-alone trial was
stopped after 7.2 years
due to an increased risk
of stroke

Key Findings
Hormone
therapy with
CEE plus MPA
for a median of
5.6 years or with
CEE alone for a
median of 7.2
years was not
associated with
risk of all-cause,
cardiovascular,
or cancer
mortality during
a cumulative
follow-up of 18
years.

Menopausal
hormone therapy
for 5 to 7 years
was not
associated with
risk of long-term
all-cause
mortality
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Implications for
Practice
Understanding
long term effects
of HRT can help
the healthcare
team guide
women to make
educated
decisions
regarding therapy
options
postmenopausal
surgery

Author(s), Year, Location

Study Design

Shuster, L. T., Rhodes, D. J.,
Gostout, B. S., Grossardt, B.
R., & Rocca, W. A. (2010).
Premature menopause or early
menopause: long-term health
consequences. Maturitas,
65(2), 161.
http://doi.org/10.1016/j.maturit
as.2009.08.003

Literature review and
meta-analysis of the
Mayo Clinic Cohort
Study of
Oophorectomy and
Aging

Sample Size and
Population
Population was found
from the Mayo Clinic
Cohort Study of
Oophorectomy And
Aging
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Purpose
Review and
summarize
current
evidence on
health
consequences
of premature
and early
menopause

Significant Risk
Factors

Key
Findings

Women who
experience
premature
menopause
(before age 40
years) or early
menopause
(between ages
40 and 45 years)
experience an
increased risk of
overall
mortality,
cardiovascular
diseases,
neurological
diseases,
psychiatric
diseases,
osteoporosis

Some of the
negative
health
effects may
be prevented
by estrogen
treatment
initiated
after the
onset of
menopause.

Estrogen
alone does
not prevent
all long-term
consequence
s, so
combination
HRT is
likely the
best course
of action

Implications for Practice

Understanding hormonal
mechanisms of menopause c
help the healthcare team guid
women toward more effectiv
combinations of HRT in ord
to increase quality of life and
reduce negative health effect
that result from early onset
menopause

Author(s), Year, Location
West SL, D’Aloisio AA, Agans RP,
Kalsbeek WD, Borisov NN, Thorp
JM. (2008) Prevalence of Low Sexual
Desire and Hypoactive Sexual Desire
Disorder in a Nationally
Representative Sample of US Women.
Arch Intern Med, 168(13):1441–1449.
doi:10.1001/archinte.168.13.1441

Study
Design
Crosssectional
study

Low sexual
desire was
defined
using the
Profile of
Female
Sexual
Function
desire
domain, and
HSDD was
defined
using the
Profile of
Female
Sexual
Function
and the
Personal
Distress
Scale

Sample Size
and Population
N=2207

755
premenopausal
women and 552
naturally and
637 surgically
menopausal
women.

nationally
representative
sample of
women aged 30
- 70 years in
study
relationships for
3 months or
longer

Table 2: Table of Evidence of Reviewed Literature
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Purpose
To estimate
the prevalence
of low sexual
desire and
hypoactive
sexual desire
disorder
(HSDD) in
US women,
focusing on
their
menopausal
status

Significant Risk
Factors

Key
Findings

Implications
for Practice

Surgical
menopause
causes more
distress regarding
low desire for
sexual activity

Prevalence
of low sexual
desire is
elevated
among
surgically
and naturally
menopausal
women

Understanding
actual and
perceived client
dissatisfaction
helps build a
trusting
relationship that
promotes
wellbeing for
women

Depression and
antidepressants
were strongly
associated with
low desire and
HSDD

Distress
about HSDD
was more
than twice as
prevalent
Current use of
among
hormonal therapy surgically
among
menopausal
menopausal
women
women did not
modify the
association
between type of
menopause and
low desire or
HSDD

List of References
Abadi, O. S., Cheraghi, M. A., Tirgari, B., Nayeri, N. D., & Rayyani, M. (2018). Feeling an
Invisible Wall: The Experience of Iranian Womens Marital Relationship After Surgical
Menopause: A Qualitative Content Analysis Study. Journal of Sex & Marital Therapy,
1-14. doi:10.1080/0092623x.2018.1440451
Beral, V., Banks, E., & Reeves, G. (2002). Evidence from Randomised Trials On The LongTerm Effects Of Hormone Replacement Therapy. Lancet, 360(9337), 942.
Birkhäuser, M. H., & Reinecke, I. (2008). Current trends in hormone replacement therapy:
perceptions and usage. Climacteric, 11(3), 192-200. doi:10.1080/13697130802060455
Buist, D. S., Newton, K. M., Miglioretti, D. L., Beverly, K., Connelly, M. T., Andrade, S.,
Kessler, L. (2004). Hormone Therapy Prescribing Patterns in the United States.
Obstetrics & Gynecology, 104(5), part 1, 1042-1050.
doi:10.1097/01.aog.0000143826.38439.af
Burrell, B., Valledor, V., Crowe, M., & Whitehead, L. (2010). Negotiating Competing
Discourses: The Decision to Take Menopausal Hormone Therapy Following Surgical
Menopause. Women & Health, 50(6), 527-543. doi:10.1080/03630242.2010.516699
Chubaty, A., Shandro, M. L., Schuurmans, N., & Yuksel, N. (2011). Practice patterns with
hormone therapy after surgical menopause. Maturitas, 6969-73.
doi:10.1016/j.maturitas.2011.02.004
Chung-Park, M. (2006). Anxiety Attacks Following Surgical Menopause: A Case Report.
Holistic Nursing Practice, 19(5), 236-240.
Crauciuc, D., Toma, O., Ungureanu, E., Bratu, M., Badoi, D., & Crauciuc, E. (2013). The effects
of hormonal therapy in natural and surgical menopause. Analele Ştiinţifice Ale
47

Universităţii Alexandru Ioan Cuza Din Iași,Sectiunea II A : Genetica Si Biologie
Moleculara, 13(4), 35-43. Retrieved from
https://doaj.org/article/ae4c7a6860be48afa9d033b8edd64495.
Danckers, L., Blümel, J. E., Witis, S., Vallejo, M. S., Tserotas, K., Sánchez, H., & ... Chedraui,
P. (2016). Personal and professional use of menopausal hormone therapy among
gynecologists: A multinational study (REDLINC VII). Maturitas, 8767-71.
doi:10.1016/j.maturitas.2016.02.015
Doty, et.al (2015). Influences of hormone replacement therapy on olfactory and cognitive
function in postmenopausal women. Neurobiology of Aging, 36(6), 2053-2059,
https://doi.org/10.1016/j.neurobiolaging.2015.02.028.
Fakkert, I., Teixeira, N., Abma, E., Slart, R., Mourits, M., Bock, G., & ... de Bock, G. H. (2017).
Bone Mineral Density and Fractures After Surgical Menopause: Systematic Review And
Meta-Analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 124(10),
1525-1535. doi:10.1111/1471-0528.14703
Fitzpatrick, L. A., Pace, C., & Wiita, B. (2000). Comparison of Regimens Containing Oral
Micronized Progesterone or Medroxyprogesterone Acetate on Quality of Life in
Postmenopausal Women: A Cross-Sectional Survey. Journal of Women’s Health &
Gender-Based Medicine, 9(4), 381-387. doi:10.1089/1524609005002069
Hersh, A., Stefanick, M. & Stafford, R. (2004). National Use of Hormone Replacement Therapy:
Annual trends and Response to Recent Evidence. JAMA, (291), 47-53.
doi:10.1001/jama.291.1.47
Jin, J. (2017). Hormone Therapy for Primary Prevention of Chronic Conditions in
Postmenopausal Women. JAMA, 318(22), 2265. doi:10.1001/jama.2017.18440
48

Kaur, N., Malla, V. G., & Gupta, S. (2017). Serum estradiol level and postmenopausal symptoms
in surgical and natural menopause. International Journal of Reproduction,
Contraception, Obstetrics and Gynecology, 6(9), 3920-3923. doi:10.18203/23201770.ijrcog20174035
Keshavarz, H., Hillis, S.D., Kieke, B.A., Marchbanks, P.A. (2002). Surveillance Summaries.
MMWR. Hysterectomy Surveillance, United States, 1994–1999; pp. 1–8.
Kokcu, A., Kurtoglu, E., Bildircin, D., Celik, H., Kaya, A., & Alper, T. (2015). ORIGINAL
RESEARCH: Does Surgical Menopause Affect Sexual Performance Differently from
Natural Menopause?. The Journal of Sexual Medicine, 121407-1414.
doi:10.1111/jsm.12891
Lobo, R. A. (2007). Menopause and stroke and the effects of hormonal therapy. Climacteric: The
Journal of The International Menopause Society, 10 Suppl 227-31.
Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, WactawskiWende J. (2017) Menopausal Hormone Therapy and Long-term All-Cause and CauseSpecific Mortality, The Women’s Health Initiative Randomized Trials. JAMA,
318(10):927–938. doi:10.1001/jama.2017.11217
Otsuki, M., Kasayama, S., Morita, S., Asanuma, N., Saito, H., Mukai, M., Koga, M. (2007)
Menopause, but not age, is an independent risk factor for fasting plasma glucose levels
in nondiabetic women. Menopause: The Journal of the North American Menopause
Society, 10:404-407. doi:10.1097/01.gme0000247014.56254.12
Pezaro, C., James, P., Mckinley, J., Shanahan, M., Young, M., & Mitchell, G. (2012). The
consequences of risk reducing salpingo-oophorectomy: The case for a coordinated

49

approach to long-term follow up post-surgical menopause. Familial Cancer, 11(3), 403410. doi:10.1007/s10689-012-9527-5
Pines, A. (2014). Surgical menopause and cognitive decline. Climacteric, 17(5), 580-582.
doi:10.3109/13697137.2014.883244
Rodriguez, M., & Shoupe, D. (2015). Surgical Menopause. Endocrinology and Metabolism
Clinics of North America, 44(3), 531-542. Retrieved from
https://doi.org/10.1016/j.ecl.2015.05.003.
Sanghvi, M. M., Aung, N., Cooper, J., Paiva, J. M., Lee, A., Zemrak, F., . . . Petersen, S. (2018).
The impact of menopausal hormone therapy (MHT) on cardiac structure and function:
Insights from the UK Biobank imaging enhancement study. PLOS ONE.
Shuster, L. T., Rhodes, D. J., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2010). Premature
menopause or early menopause: long-term health consequences. Maturitas, 65(2), 161.
http://doi.org/10.1016/j.maturitas.2009.08.003
Siyam, T., Sultani, H., Ross, S., Chatterley, T., & Yuksel, N. (2017). Evaluating the content and
development of decision aid tools for the management of menopause: A scoping review.
Maturitas, 106, 80-86. doi:10.1016/j.maturitas.2017.09.006
Topatan, S., & Yıldız, H. (2012). Symptoms Experienced by Women Who Enter into Natural
and Surgical Menopause and Their Relation to Sexual Functions. Health Care for
Women International, 33(6), 525-539. doi:10.1080/07399332.2011.646374
The North American Menopause Society. (2017, July). The 2017 hormone therapy position
statement of The North American Menopause Society. Menopause, 728-753.
doi:10.1097/GME.0000000000000921

50

Tucker, P. E., Bulsara, M. K., Salfinger, S. G., Tan, J. J., Green, H., & Cohen, P. A. (2016). The
Effects Of Pre-Operative Menopausal Status And Hormone Replacement Therapy (HRT)
On Sexuality And Quality Of Life After Risk-Reducing Salpingo-Oophorectomy.
Maturitas, 85, 42-48. doi:10.1016/j.maturitas.2015.12.004
West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. (2008) Prevalence
of Low Sexual Desire and Hypoactive Sexual Desire Disorder in a Nationally
Representative Sample of US Women. Arch Intern Med, 168(13):1441–1449.
doi:10.1001/archinte.168.13.1441
Writing Group for the Women's Health Initiative Investigators. (2002). Risks and Benefits of
Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the
Women’s Health Initiative Randomized Controlled Trial. Obstetrical & Gynecological
Survey, 57(11), 750-752. doi:10.1097/00006254-200211000-00019

51

